Laura E. Niklason - Sep 15, 2022 Form 4 Insider Report for Humacyte, Inc. (HUMA)

Role
President, CEO and Director, Director, 10%+ Owner
Signature
/s/ Laura E. Niklason by Dale A. Sander as Attorney-in-Fact
Stock symbol
HUMA
Transactions as of
Sep 15, 2022
Transactions value $
-$6,090,000
Form type
4
Date filed
9/19/2022, 04:36 PM
Previous filing
Jun 13, 2022
Next filing
Dec 12, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HUMA Common Stock Sale -$6.09M -1.52M -7.44% $4.00 18.9M Sep 15, 2022 By Ayabudge LLC F1
holding HUMA Common Stock 1.16M Sep 15, 2022 Direct
holding HUMA Common Stock 510K Sep 15, 2022 By spouse
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This sale was made by an entity controlled by the spouse of Laura Niklason, the Reporting Person. This sale was done as a block trade to an existing investor of Humacyte, Inc. Laura Niklason is treated as indirectly beneficially owning the shares sold, resulting in the requirement to file this Form 4. However, no shares directly owned by Laura Niklason were sold in this transaction.